According to TipRanks.com, Schock is a 2-star analyst with an average return of 2.9% and a 53.3% success rate. Schock covers the Healthcare sector, focusing on stocks such as InfuSystem Holdings, ...

In a report released yesterday, Anderson Schock from B. Riley Securities reiterated a Buy rating on Inogen, with a price target of $14.00. The company’s shares closed yesterday at $6.36.

Inogen to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use ...

GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced preliminary, ...

Powered by Money.com - Yahoo may earn commission from the links above. The Company estimates preliminary, unaudited total revenue in the fourth quarter of 2025 to be approximately $82 million, ...

Investing.com -- Inogen Inc (NASDAQ:INGN) stock gained 5.7% on Wednesday after the medical technology company announced the launch of its Aurora CPAP masks, expanding its product portfolio into the ...

Engineered for superior comfort, reliability, and usability, Aurora Masks establishes Inogen’s presence in the growing sleep-therapy market and expands Inogen’s addressable market opportunity. The ...

GOLETA, Calif. (AP) — GOLETA, Calif. (AP) — Inogen Inc. (INGN) on Wednesday reported a loss of $5.3 million in its third quarter. On a per-share basis, the Goleta, California-based company said it had ...

Inogen’s proprietary Inogen One and Inogen Rove portable oxygen concentrators extract and concentrate ambient air to deliver ...